BIIB vs HAIN · P/E 21, rev $9.89B vs rev $1.56B
Biogen Inc (BIIB) versus The Hain Celestial Group Inc (HAIN) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
The Hain Celestial Group Inc (HAIN) is a packaged foods company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported HAIN revenue for 2025-06-30 was $1.56B. Net income was -$530.8M. HAIN currently screens at market cap $143.5M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. HAIN currently screens at market cap $143.5M.
Not investment advice. Open the BIIB and HAIN stock pages for the full models.
Not investment advice.